TerminatedPhase 1NCT00376519
Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Principal Investigator
- Claudio G. Brunstein, MD, PhD, FNP-BCMasonic Cancer Center, University of Minnesota
- Intervention
- cyclophosphamide(drug)
- Enrollment
- 3 enrolled
- Eligibility
- 18-45 years · All sexes
- Timeline
- 2007 – 2008
Study locations (1)
- Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00376519 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.